ailanthone has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, X; Li, J; Li, K; Li, Y; Liu, N; Liu, P; Peng, C; Wei, H; Yi, X; Yu, P; Zhang, D; Zhao, S; Zhu, L; Zhu, S | 1 |
1 other study(ies) available for ailanthone and Malignant Melanoma
| Article | Year |
|---|---|
The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Humans; Melanoma; Mice; Molecular Docking Simulation; Tumor Microenvironment | 2022 |